(Q37780728)

PubMed publication ID

20718076

23 August 2017

title

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

author name string

Louis S Matza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

Robert Morlock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

Chris Sexton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

Karen Malley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

Douglas Feltner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

publication date

18 August 2010

1 reference

PubMed publication ID

20718076

International Journal of Methods in Psychiatric Research

23 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

page(s)

223-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

The assessment of anxiety states by rating

13 May 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMPR.323

Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMPR.323

A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care

21 January 2018

1 reference

12 December 2020

Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients

1 reference

12 December 2020

The assessment of changes in anxiety in a drug trial: a comparison of methods.

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders

1 reference

12 December 2020

Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A)

1 reference

12 December 2020

Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

1 reference

12 December 2020

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial

1 reference

12 December 2020

Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis.

1 reference

12 December 2020

Estimation of symptom-free days in generalized anxiety disorder

1 reference

12 December 2020

Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder

1 reference

12 December 2020

Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study

1 reference

12 December 2020

Effectiveness of St John's wort in major depression: a randomized controlled trial

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Taking the measure of anxiety and depression. Validity of the reconstructed Hamilton scales

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

12 December 2020

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

1 reference

12 December 2020

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder

1 reference

12 December 2020

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

12 December 2020

Venlafaxine extended-release: a review of its use in the management of major depression

1 reference

12 December 2020

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

1 reference

12 December 2020

Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale

1 reference

12 December 2020

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

1 reference

12 December 2020

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder

1 reference

12 December 2020

Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain

1 reference

12 December 2020

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function

1 reference

12 December 2020

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

1 reference

12 December 2020

The hospital anxiety and depression scale

1 reference

12 December 2020

The efficacy of divalproex sodium in the treatment of agitation associated with major depression

1 reference

12 December 2020

Open-label trial of riluzole in generalized anxiety disorder

1 reference

12 December 2020

Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction.

1 reference

12 December 2020

Implications of using different cut-offs on symptom severity scales to define remission from depression

1 reference

12 December 2020

Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.

1 reference

12 December 2020

Reliability and validity of the Hamilton Anxiety Rating Scale in an adolescent sample

1 reference

12 December 2020

Generalized anxiety or depression measured by the Hamilton Anxiety Scale and the Melancholia Scale in patients before and after cardiac surgery.

1 reference

12 December 2020

Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study

1 reference

12 December 2020

Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints.

1 reference

12 December 2020

Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study

1 reference

12 December 2020

Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?

1 reference

12 December 2020

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Identifiers

DOI

10.1002/MPR.323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

release_folku3pctng4xg4gqp53rkegvy

13 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/folku3pctng4xg4gqp53rkegvy

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878292&resulttype=core&format=json

13 May 2020

PubMed publication ID

20718076

1 reference